Welcome to Edition 8.32 of the Rocket Report! The big news this week is NASA's shake-up of the Artemis program. On paper, at least, the changes appear to be quite sensible. Canceling the big new upper stage for the Space Launch System rocket and replacing it with a commercial upper stage, almost certainly United Launch Alliance's Centaur stage, should result in cost savings. The changes also relie...
Welcome to Edition 8.32 of the Rocket Report! The big news this week is NASA's shake-up of the Artemis program. On paper, at least, the changes appear to be quite sensible. Canceling the big new upper stage for the Space Launch System rocket and replacing it with a commercial upper stage, almost certainly United Launch Alliance's Centaur stage, should result in cost savings. The changes also relieve some of the pressure for SpaceX and Blue Origin to rapidly demonstrate cryogenic refueling in low-Earth orbit. The Artemis III mission is now a low-Earth orbit mission, using SLS and the Orion spacecraft to dock with one or both of the Artemis program's human-rated lunar landers just a few hundred miles above the Earth—no refueling required. Artemis IV will now be the first lunar landing attempt. As always, we welcome reader submissions . If you don't want to miss an issue, please subscribe using the box below (the form will not appear on AMP-enabled versions of the site). Each report will include information on small-, medium-, and heavy-lift rockets, as well as a quick look ahead at the next three launches on the calendar. Sentinel missile nears first flight. The US Air Force’s new Sentinel intercontinental ballistic missile is on track for its first test flight next year, military officials reaffirmed last week. The LGM-35A Sentinel will replace the Air Force’s Minuteman III fleet, in service since 1970, with the first of the new missiles due to become operational in the early 2030s. But it will take longer than that to build and activate the full complement of Sentinel missiles and the 450 hardened underground silos to house them, Ars reports . Read full article Comments
JADE101 Phase 1 healthy volunteer interim data expected in the second quarter of 2026; Phase 2 clinical trial in patients with IgA nephropathy expected to begin mid-2026 with preliminary data anticipated in 2027 JADE201, a half-life extended afucosylated anti-BAFF receptor antibody, expected to advance into first-in-human clinical trial in rheumatoid arthritis patients in the second quarter of 202...
JADE101 Phase 1 healthy volunteer interim data expected in the second quarter of 2026; Phase 2 clinical trial in patients with IgA nephropathy expected to begin mid-2026 with preliminary data anticipated in 2027 JADE201, a half-life extended afucosylated anti-BAFF receptor antibody, expected to advance into first-in-human clinical trial in rheumatoid arthritis patients in the second quarter of 2026; interim data anticipated in 2027 Third development candidate, JADE301, nominated; Phase 1 clinical trial expected to commence in the first half of 2027 $336 million of cash, cash equivalents, and investments as of December 31st, 2025 expected to provide runway into the first half of 2028 SAN FRANCISCO and VANCOUVER, British Columbia, March 06, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade” or the “Company”) (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced financial results for the fourth quarter and full year ending December 31, 2025, and provided a corporate update. Tom Frohlich, Chief Executive Officer of Jade Biosciences, commented: “We closed 2025 with strong momentum, having initiated the JADE101 Phase 1 healthy volunteer study, continued to advance JADE201 toward the clinic, and further strengthened our team and balance sheet. As we look ahead, our focus is on delivering interim, biomarker-rich Phase 1 data for JADE101, initiating the Phase 2 clinical trial in IgA nephropathy, and starting first-in-human dosing for the Phase 1 clinical trial of JADE201. With multiple clinical milestones approaching and cash runway expected to extend into the first half of 2028, we are well positioned to execute on our near-term priorities while continuing to build a differentiated pipeline with the goal of delivering best-in-class, disease-modifying autoimmune therapies to patients.” Pipeline and Corporate Updates JADE101: potentially best-in-class selective anti-APRIL monoclonal antibody for IgA...
Phase 3 pivotal program initiation for BPL-003 in treatment-resistant depression remains on track for Q2 2026 following successful End‑of‑Phase 2 meeting with the U.S. Food and Drug Administration On-track for VLS-01 Phase 2 Elumina trial topline data readout anticipated in H2 2026 Exploratory Phase 2a trial of EMP-01 in Social Anxiety Disorder met its primary safety and tolerability objective and...
Phase 3 pivotal program initiation for BPL-003 in treatment-resistant depression remains on track for Q2 2026 following successful End‑of‑Phase 2 meeting with the U.S. Food and Drug Administration On-track for VLS-01 Phase 2 Elumina trial topline data readout anticipated in H2 2026 Exploratory Phase 2a trial of EMP-01 in Social Anxiety Disorder met its primary safety and tolerability objective and demonstrated clinically meaningful improvements across key efficacy measures Cash runway through the planned early-2029 topline readouts from both Phase 3 pivotal studies Virtual Investor Day scheduled for March 6, 2026 NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or the “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient mental health treatments, today announced fourth quarter and full year 2025 financial results and provided key regulatory, clinical and business updates. “Following our strategic combination of atai Life Sciences and Beckley Psytech, and U.S. redomiciliation, we have entered a pivotal execution phase,” said Srinivas Rao, M.D., Ph.D., Chief Executive Officer and Co-Founder of AtaiBeckley. “We received constructive feedback from the FDA on the Phase 3 development plan for BPL-003 in treatment-resistant depression, positioning us to initiate our pivotal program in the second quarter of 2026. We also reported positive topline results from our exploratory Phase 2a study of EMP-01 in Social Anxiety Disorder, which met its primary safety objective and demonstrated clinically meaningful improvements across key efficacy measures after just two administrations and without adjunct psychotherapy. With multiple clinical catalysts ahead and capital expected to fund operations into 2029, we believe AtaiBeckley is well positioned to advance a differentiated portfolio of rapid-acting mental health therapies.” Program Updates and Antic...
Unihertz’s booth at MWC was a little out of the way, but those who did find it all seemed to want to pick up the Titan Elite 2. Sure, the cosmic orange color attracted attention, and the QWERTY keyboard reminded one showgoer of his old BlackBerry. But once I picked it up, I could see why it was so popular. It’s slim, light, and pocketable, and the physical keys just beg to be pressed. I felt unenc...
Unihertz’s booth at MWC was a little out of the way, but those who did find it all seemed to want to pick up the Titan Elite 2. Sure, the cosmic orange color attracted attention, and the QWERTY keyboard reminded one showgoer of his old BlackBerry. But once I picked it up, I could see why it was so popular. It’s slim, light, and pocketable, and the physical keys just beg to be pressed. I felt unencumbered, which I can’t say about the phone I’m currently using. I didn’t want to put it down, and based on the steady stream of visitors I saw at the booth, I wasn’t alone. As usual, MWC offered a bunch of odd and delightful ideas about phones that aren’t just slabs of glass and aluminum. This year, I saw a phone with an electric igniter (it wasn’t working either time I tried to see it in action), a phone with a DJI Osmo-looking gimbal cam attached, even phones for pets. Will any of these ideas prove to be winners in the long run? Probably not, but it’s nice to imagine something different. Related Phones are going to get weird next week In between the oddball phones, another trend emerged in places like the Unihertz booth: phones that aren’t your main phone. This isn’t a brand-new idea, but the concept of a simplified device that provides a better typing experience, or gives you a little vacation from your regular phone’s constant nagging, seems to be gaining momentum. In almost every case, these are phones that could be your main phone, and Unihertz in particular has plenty of fans using the company’s existing devices this way. The Titan Elite 2 runs Android 16, and Unihertz promises OS upgrades up to Android 20. Watching vertical videos on the squarish 4-inch screen isn’t going to be the best experience, but there’s nothing to stop you from doing it. But the Elite 2 might be most appealing as a device when you don’t plan on watching a lot of TikTok videos — maybe if you want to actively discourage yourself from doing so, even. There are a few overlapping intentions behind...
Nearmap/DigitalVision via Getty Images Article Thesis On Thursday, Canadian Natural Resources ( CNQ ) announced its Q4 earnings results. The company beat estimates easily, showed strong business growth compared to one year earlier, and announced another dividend increase on top of that. In recent weeks, shares have risen nicely, and they are not the bargain they were a while ago -- but I remain bu...
Nearmap/DigitalVision via Getty Images Article Thesis On Thursday, Canadian Natural Resources ( CNQ ) announced its Q4 earnings results. The company beat estimates easily, showed strong business growth compared to one year earlier, and announced another dividend increase on top of that. In recent weeks, shares have risen nicely, and they are not the bargain they were a while ago -- but I remain bullish on Canadian Natural Resources. Past Coverage I have written about Canadian Natural Resources here on Seeking Alpha in the past, most recently in January, when I published this article . I recommended buying CNQ back then, arguing that Venezuela-related fears were way overblown. So far, this thesis has worked out well, as Canadian Natural Resources has risen by a very nice 30% in the ~2 months since that article was published. With the company releasing its most recent earnings results on Thursday, it's time for me to update my views on the company today. What Happened? On Wednesday morning, Canadian Natural Resources announced its Q4 earnings results. The key numbers looked like this: Canadian Natural Resources Q4 earnings results (Seeking Alpha) We see that CNQ outperformed the analyst consensus widely when it comes to its earnings per share, with the C$0.82 result being a hefty 17% higher than expected. That being said, net profits and earnings per share are not the best metrics to evaluate a company like CNQ, I believe -- high non-cash depreciation charges for its oil sands mining assets make net profits look rather low compared to cash flows, which is why I think that looking at cash flow/funds flow is ideal. Canadian Natural Resources: Tailwinds From Higher Oil Prices Escalation in the Middle East has made oil prices jump significantly over the last couple of days, with investors fearing supply disruptions for oil exporters that ship oil through the Strait of Hormuz. Higher oil prices are, all else equal, positive for oil producers, including Canadian Natural Res...
Saving for retirement is important, but when it's decades away and you've got bills due today, it's understandable if it falls lower on the priority list. You don't need to pay off all your debts before you can tackle retirement savings, but if you have high-interest debt, it's worth getting it out of the way so you have more wiggle room in your budget. The right strategy for you will depend on ho...
Saving for retirement is important, but when it's decades away and you've got bills due today, it's understandable if it falls lower on the priority list. You don't need to pay off all your debts before you can tackle retirement savings, but if you have high-interest debt, it's worth getting it out of the way so you have more wiggle room in your budget. The right strategy for you will depend on how much and which type(s) of debt you have. Here are three popular strategies you can use to get your high-interest debt under control. 1. Snowball or avalanche method The debt snowball and debt avalanche methods are do-it-yourself strategies you can use to pay off multiple debts without taking out new loans. You start by making a list of all your debts, including the creditor name, balance, interest rate, minimum payment, and payment due date. With both strategies, you make minimum payments on each of your debts every month. The snowball method has you put any extra cash toward the debt with the smallest balance first until it's paid off. Then, you move on to the debt with the next-smallest balance, and so on. The avalanche method does the same thing except you focus on the debt with the highest interest rate first. 2. Balance transfer card A balance transfer card can work well if you have expensive credit card debt that you're confident you can pay off in the introductory 0% interest-rate period. You'll pay a one-time fee to do the balance transfer, but then, your balance won't grow for months. This can make it much easier to pay back what you owe. However, once the introductory period ends, any remaining balance will begin to accrue interest at the standard rate. Make sure you're prepared for this if you haven't paid off the entire amount at that point. 3. Debt consolidation loan A debt consolidation loan is a new loan you take out to pay off other debts. It could get you a lower monthly payment and may reduce your overall interest payments. Debt consolidation loans are o...
Berkshire CEO Greg Abel Commits Salary To Buying Company Stock Greg Abel said he plans to put all of his after-tax compensation into shares of Berkshire Hathaway for as long as he runs the company, according to Yahoo Finance/Bloomberg . He recently followed through by buying about $15.3 million of Berkshire stock, according to a regulatory filing. Abel said repeating the purchase each year after t...
Berkshire CEO Greg Abel Commits Salary To Buying Company Stock Greg Abel said he plans to put all of his after-tax compensation into shares of Berkshire Hathaway for as long as he runs the company, according to Yahoo Finance/Bloomberg . He recently followed through by buying about $15.3 million of Berkshire stock, according to a regulatory filing. Abel said repeating the purchase each year after the company reports results could total “hundreds of millions” of dollars over time. “Absolute alignment with our shareholders, our partners, our owners is critical,” Abel said in an interview with CNBC on Thursday. “I already have some shares, but the goal was to continue to demonstrate alignment with them.” Bloomberg writes that the conglomerate also restarted its share repurchase program on Wednesday after leadership concluded the company’s “intrinsic value” exceeded its trading price. Following the announcement, the stock rose as much as 2% in early trading in New York on Thursday. Earlier in the week, Berkshire shares declined after the firm reported fourth-quarter results showing operating profit fell 30%, largely due to a 54% drop in insurance underwriting income. Investors had been looking for clues on Abel’s buyback strategy, particularly since Berkshire had gone six consecutive quarters without repurchasing shares. In his first annual shareholder letter last week, Abel reiterated the company’s long-standing approach to returning capital and signaled that a dividend remains unlikely. “We’ve maintained that we will retain a dollar if we see the opportunity to create more than a dollar for our shareholders —and that’s been the test,” Abel said. “So if we didn’t meet that test, we’d do a dividend.” Abel added that repurchasing stock won’t prevent Berkshire from deploying its roughly $373 billion cash reserve elsewhere. “There’s also ‘Do we acquire stock?’ And when we’re looking at companies: ‘Do we acquire whole companies also?’ And then there’s the ‘Do we acquire equi...
Buying strong, best-in-class technology and artificial intelligence stocks into weakness is something long-term investors should consider doing to start March. The bulls stepped up and bought stocks to defend the Nasdaq’s 200-day moving average mid-week despite escalating attacks in Iran and the surrounding region. Of course, a lot could change over the weekend and in the coming days and weeks giv...
Buying strong, best-in-class technology and artificial intelligence stocks into weakness is something long-term investors should consider doing to start March. The bulls stepped up and bought stocks to defend the Nasdaq’s 200-day moving average mid-week despite escalating attacks in Iran and the surrounding region. Of course, a lot could change over the weekend and in the coming days and weeks given the dynamic and rapidly evolving situation in the Middle East. Image Source: Zacks Investment Research No matter what happens in the near-term, investors must remember that buying stocks amid downturns and chaotic times is a proven strategy over the long haul. Wall Street has also largely shrugged off other conflicts in recent years. Buy AI and Tech Stocks On the Dip in March and Hold It is time for investors to cut through the noise and look to the facts on the ground. The two things that move the market—earnings and interest rates—are supporting stocks. Nvidia’s Q4 report and outlook confirmed what Wall Street already knew. Despite some AI bubble worries, the spending spree is heating up. AI chip manufacturer Taiwan Semi was the first big tech firm to raise its 2026 capex guidance back in early January to between $52 billion and $56 billion, blowing away 2025’s $40.9 billion. AI hyperscalers are projected to spend roughly $530 billion in capex this year, up from around $400 billion last year. This figure is likely to keep climbing after the stellar stretch of guidance from the Mag 7 and beyond. The chart below highlights that the outlook for Q1 2026 Tech sector earnings has surged to 24% up from 18% in mid-January and 12% back in early October. Image Source: Zacks Investment Research Wall Street is also excited that earnings growth is spreading across nearly every pocket of the economy, with 15 out of 16 Zacks sectors set to post YoY EPS expansion in 2026. On the interest rate front, the big money is still betting that the Fed will cut rates again in the back half of 2...
There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on WEX (WEX – Research Report), Broadcom (AVGO – Research Report) and Pagseguro Digital (PAGS – Research Report) with bullish sentiments. WEX (WEX) Bank of America Securities analyst Mihir Bhatia maintained a Buy rating on WEX today and set a price target of $180.00. The company’s shares closed last Wednesd...
There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on WEX (WEX – Research Report), Broadcom (AVGO – Research Report) and Pagseguro Digital (PAGS – Research Report) with bullish sentiments. WEX (WEX) Bank of America Securities analyst Mihir Bhatia maintained a Buy rating on WEX today and set a price target of $180.00. The company’s shares closed last Wednesday at $164.79. According to TipRanks.com, Bhatia is a 4-star analyst with an average return of 6.7% and a 57.0% success rate. Bhatia covers the Financial sector, focusing on stocks such as Bread Financial Holdings, Capital One Financial, and Synchrony Financial. ;'> Currently, the analyst consensus on WEX is a Hold with an average price target of $162.33. See the top stocks recommended by analysts >> Broadcom (AVGO) Benchmark Co. analyst Cody Acree reiterated a Buy rating on Broadcom today and set a price target of $485.00. The company’s shares closed last Wednesday at $317.53. According to TipRanks.com, Acree is a 5-star analyst with an average return of 25.9% and a 66.0% success rate. Acree covers the Technology sector, focusing on stocks such as Advanced Micro Devices, Silicon Laboratories, and ARM Holdings PLC ADR. ;'> The word on The Street in general, suggests a Strong Buy analyst consensus rating for Broadcom with a $452.92 average price target, a 43.5% upside from current levels. In a report released today, TipRanks – PerPlexity also upgraded the stock to Buy with a $347.00 price target. Pagseguro Digital (PAGS) UBS analyst Kaio Da Prato maintained a Buy rating on Pagseguro Digital yesterday and set a price target of $14.00. The company’s shares closed last Wednesday at $10.57. According to TipRanks.com, Prato is a 4-star analyst with an average return of 18.3% and a 69.0% success rate. Prato covers the Financial sector, focusing on stocks such as Grupo Financiero Galicia SA, Banco BBVA Argentina, and Grupo Supervielle SA. ;'> The word on The Street in general, sugg...
States sue to block Trump’s latest 10% import tariffs, BlackRock sparks fresh fears about private credit, Berkshire’s new CEO restarted company share buybacks, and more news to start your day.
States sue to block Trump’s latest 10% import tariffs, BlackRock sparks fresh fears about private credit, Berkshire’s new CEO restarted company share buybacks, and more news to start your day.
The service was called "the best deal in gaming" for consumers when it was first launched in 2017, but it has raised questions over profitability and its impact on the purchase of full-price software.
The service was called "the best deal in gaming" for consumers when it was first launched in 2017, but it has raised questions over profitability and its impact on the purchase of full-price software.
German media publisher Axel Springer SE is set to buy the Telegraph Media Group for £500 million ($666 million), potentially torpedoing the current bid from Daily Mail & General Trust Plc. , the Financial Times reported , citing people familiar with the matter. A deal could be agreed as early as today, according to the FT. Representatives for the Telegraph and Axel Springer did not immediately res...
German media publisher Axel Springer SE is set to buy the Telegraph Media Group for £500 million ($666 million), potentially torpedoing the current bid from Daily Mail & General Trust Plc. , the Financial Times reported , citing people familiar with the matter. A deal could be agreed as early as today, according to the FT. Representatives for the Telegraph and Axel Springer did not immediately respond to a request for comment. An acquisition would be a coup for Axel Springer Chief Executive Officer Mathias Dopfner , who has been on a dealmaking spree over the past few years in an attempt to transform the company into a global media powerhouse. It would also see a storied newspaper, seen as the house newspaper of the opposition Conservative party, come into German rather than British ownership. The £500 million bid by fellow right-leaning UK newspaper group DMGT has dragged on after the Labour government triggered regulatory probes into the proposed deal last month. The deal would potentially end three years of uncertainty over the newspaper publisher’s ownership. The Daily Mail owner reached a deal to buy the publisher of the Daily and Sunday Telegraph in November, after US private equity firm RedBird Capital Partners withdrew its offer amid backlash from the newspaper’s own staff.
He raised the issue of getting people in the region to the airport in Oman to get on charter flights, adding that they "have to be able to travel safely in buses and cars without being hit by drone or missile fire".
He raised the issue of getting people in the region to the airport in Oman to get on charter flights, adding that they "have to be able to travel safely in buses and cars without being hit by drone or missile fire".
Qnity Electronics ( Q ) has announced a $61.5M investment in a new semiconductor research and manufacturing facility in Taiwan. The new facility will support the production of the most advanced chip manufacturing applications. The site will feature production areas, state-of-the-art clean rooms, warehousing infrastructure, research labs, and dedicated office space designed to enable high-performan...
Qnity Electronics ( Q ) has announced a $61.5M investment in a new semiconductor research and manufacturing facility in Taiwan. The new facility will support the production of the most advanced chip manufacturing applications. The site will feature production areas, state-of-the-art clean rooms, warehousing infrastructure, research labs, and dedicated office space designed to enable high-performance manufacturing at scale. Expected to begin operations in early 2027, this site expands Qnity’s existing presence in the Hsinchu Science Park. Source: Press Release More on Qnity Electronics Qnity Electronics: An Under The Radar Gem From DuPont's Spin-Off Qnity Electronics, Inc. 2025 Q4 - Results - Earnings Call Presentation Qnity Electronics, Inc. (Q) Q4 2025 Earnings Call Transcript Qnity Electronics targets $100M EBITDA run rate improvement by 2028 through transformation plan Qnity Electronics beats top-line and bottom-line estimates; introduces FY26 outlook
BE Semiconductor Industries NV fell as much as 17% on a report that major memory chipmakers are looking at new standards that could delay demand for the Dutch company’s technology. Chipmakers are weighing changes to their thickness standards for the next generation of high-bandwidth-memory chips that would mean they don’t need to upgrade their processes for bonding semiconductor components togethe...
BE Semiconductor Industries NV fell as much as 17% on a report that major memory chipmakers are looking at new standards that could delay demand for the Dutch company’s technology. Chipmakers are weighing changes to their thickness standards for the next generation of high-bandwidth-memory chips that would mean they don’t need to upgrade their processes for bonding semiconductor components together, South Korean news website ZDNet reported on Friday, citing discussions at the Joint Electron Device Engineering Council , which includes Samsung Electronics Co. and SK Hynix Inc. as members. The changes under discussion, allowing for thicker chips, would reduce demand for a key BE Semi product, so called hybrid-bonding technology for efficiently packaging layers of a semiconductor to achieve higher performance. A representative for BE Semi couldn’t immediately be reached. BE Semi shares fell 16% to €159.30 in Amsterdam trading at 12:22 p.m. after earlier dropping as much as 17%, the biggest intraday decline since July 2024. Fears of delayed industry adoption of hybrid bonding also rattled BE Semi’s stock in 2024. If Jedec relaxes the height standards for high-bandwidth-memory chips, “then there is a possibility that DRAM companies will continue for longer” on older technology before adopting hybrid bonding, Michael Roeg, an analyst at Degroof Petercam said. BE Semi’s Chief Executive Officer Richard Blickman told investors during earnings in February that 2026 would be “a very important year to understand the adoption of hybrid bonding for HBM stacking” as Samsung will share its roadmap to adoption of the hybrid bonding technology.
1. Four Chinese embodied artificial intelligence (AI) companies—Unitree Robotics, Galbot, MagicLab, and Noetix Robotics—showcased their advanced humanoid robots at this year’s nationally televised Spring Festival Gala, performing complex martial arts, comedy sketches, and starring in a short film alongside top human entertainers. The event demonstrated a significant technological leap from last ye...
1. Four Chinese embodied artificial intelligence (AI) companies—Unitree Robotics, Galbot, MagicLab, and Noetix Robotics—showcased their advanced humanoid robots at this year’s nationally televised Spring Festival Gala, performing complex martial arts, comedy sketches, and starring in a short film alongside top human entertainers. The event demonstrated a significant technological leap from last year, where robots only managed simple dance routines. The improvement was attributed to new AI algorithms and 3D lidar technology, enabling robots to execute acrobatics like table-vaulting parkour and aerial flips. Despite these advances, real-world applications of these robots remain mostly limited to entertainment and basic customer service, with broader industrial and consumer usage just starting to emerge due to ongoing technological and cost barriers [para. 1][para. 2][para. 3][para. 4][para. 5][para. 6]. 2. Chinese robotics companies are pushing to transition their humanoid robots from stage performances to industrial and consumer use. For instance, UBTech Robotics has deployed robots for vehicle assembly lines and aims for its robots to reach 80% human worker efficiency by 2027, from about 30% today with over 90% accuracy. Robot Era's logistics robots perform at about 70% of human worker efficiency, with the goal of reaching 90% for mass marketability. Consumer-targeted robots are also being introduced, like Noetix's home education robot set for release in April. However, no robot currently delivers a positive return on investment in any single application, and many units have been removed from factories due to performance shortcomings [para. 7][para. 8][para. 9][para. 10][para. 11][para. 12][para. 13][para. 14][para. 15][para. 16]. 3. One of the main obstacles to advancing humanoid robots is the lack of sufficient real-world training data. Unlike large language models trained on vast internet data, robots need physically recorded motion data, which is much scarcer an...